- Top Workplaces
- Kymera Therapeutics
Kymera Therapeutics
Kymera is a biopharmaceutical company pioneering the field of targeted protein degradation, a transformative approach to address disease targets and pathways inaccessible with conventional therapeutics. Kymera’s Pegasus platform is a powerful drug discovery engine, advancing novel small molecule programs designed to harness the body’s innate protein recycling machinery to degrade dysregulated, disease-causing proteins. With a focus on undrugged nodes in validated pathways, Kymera is advancing a pipeline of novel therapeutic candidates designed to address the most promising targets and provide patients with more effective treatments. Kymera’s initial programs target IRAK4, IRAKIMiD, and STAT3 within the IL-1R/TLR or JAK/STAT pathways, and the MDM2 oncoprotein, providing the opportunity to treat patients with a broad range of immune-inflammatory diseases, hematologic malignancies, and solid tumors.
Purpose
Our shared values and a deep commitment to improving patients’ lives are the guiding principles that drive our work and connect our diverse and experienced teams to Kymera’s mission. We strive to fully engage our people by creating experiences like no other, empowering them to be their best selves and inspiring how we live and work.
Vision
Reinvent the treatment of human disease.
Mission
Build a global medicines company that harnesses novel modalities to revolutionize healthcare.
Values
- Pioneer
- We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines.
Recent Awards
2023
2022
Company Snapshots
